NCS Multistage Holdings (NCSM) Research & Development (2024 - 2026)

NCS Multistage Holdings has reported Research & Development for 3 years, with the latest figure at $613000.0 in Q2 2026.

• On a quarterly basis, Research & Development rose 6.06% year-over-year to $613000.0 in Q2 2026; TTM through Jun 2026 was $2.5 million, a 10.67% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 15.89% from the prior year.
• Research & Development was $613000.0 for Q2 2026 at NCS Multistage Holdings, up from $587000.0 in the prior quarter.
• The five-year high for Research & Development was $656000.0 in Q3 2025, with the low at $501000.0 in Q2 2024.
• Average Research & Development over 3 years is $571000.0, with a median of $576500.0 recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Research & Development climbed 20.15% in 2025, then climbed 2.09% in 2026.
• Over 3 years, Research & Development stood at $531000.0 in 2024, then increased by 15.25% to $612000.0 in 2025, then gained by 0.16% to $613000.0 in 2026.
• The last three Research & Development figures came in at $613000.0 (Q2 2026), $587000.0 (Q1 2026), and $612000.0 (Q4 2025), per Business Quant data.